And the data at ESMO21 is…
Not what many might have expected before the meeting.
Many presenters will likely make claims for a particular regimen or treatment changing the standard of care, but few will really make us stop and go… WOW!
One trial has had this effect at ESMO this year thus far.
So what’s the skinny?
BSB subscribers can read more on our latest update and commentary from the ESMO conference – you can log-in or click to access our latest analysis.
This content is restricted to subscribers